
Yevgeny Valenrod
Examiner (ID: 18322)
| Most Active Art Unit | 1621 |
| Art Unit(s) | 1628, 1621, 1672 |
| Total Applications | 1499 |
| Issued Applications | 1070 |
| Pending Applications | 102 |
| Abandoned Applications | 358 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17369851
[patent_doc_number] => 20220024903
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => POLYMOROPHS OF 5-AZA-4'-THIO-2'-DEOXYCYTIDINE
[patent_app_type] => utility
[patent_app_number] => 17/384345
[patent_app_country] => US
[patent_app_date] => 2021-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18525
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17384345
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/384345 | Polymorophs of 5-aza-4'-thio-2'-deoxycytidine | Jul 22, 2021 | Issued |
Array
(
[id] => 19104577
[patent_doc_number] => 11957648
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-16
[patent_title] => Method of initiating or escalating dofetilide dose and formulations therefor
[patent_app_type] => utility
[patent_app_number] => 17/380413
[patent_app_country] => US
[patent_app_date] => 2021-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3585
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17380413
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/380413 | Method of initiating or escalating dofetilide dose and formulations therefor | Jul 19, 2021 | Issued |
Array
(
[id] => 19324851
[patent_doc_number] => 12042504
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-23
[patent_title] => Injectable fosaprepitant composition
[patent_app_type] => utility
[patent_app_number] => 17/379999
[patent_app_country] => US
[patent_app_date] => 2021-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3583
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17379999
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/379999 | Injectable fosaprepitant composition | Jul 18, 2021 | Issued |
Array
(
[id] => 20106892
[patent_doc_number] => 12357590
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-15
[patent_title] => Binge behavior regulators
[patent_app_type] => utility
[patent_app_number] => 17/371626
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8559
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17371626
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/371626 | Binge behavior regulators | Jul 8, 2021 | Issued |
Array
(
[id] => 17183723
[patent_doc_number] => 20210330608
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => BINGE BEHAVIOR REGULATORS
[patent_app_type] => utility
[patent_app_number] => 17/371564
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13632
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17371564
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/371564 | Binge behavior regulators | Jul 8, 2021 | Issued |
Array
(
[id] => 20106892
[patent_doc_number] => 12357590
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-15
[patent_title] => Binge behavior regulators
[patent_app_type] => utility
[patent_app_number] => 17/371626
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8559
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17371626
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/371626 | Binge behavior regulators | Jul 8, 2021 | Issued |
Array
(
[id] => 19372863
[patent_doc_number] => 12064402
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-20
[patent_title] => Binge behavior regulators
[patent_app_type] => utility
[patent_app_number] => 17/371511
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13651
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17371511
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/371511 | Binge behavior regulators | Jul 8, 2021 | Issued |
Array
(
[id] => 17356711
[patent_doc_number] => 20220017507
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-20
[patent_title] => PI-Kinase Inhibitors with Anti-Infective Activity
[patent_app_type] => utility
[patent_app_number] => 17/371653
[patent_app_country] => US
[patent_app_date] => 2021-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29862
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17371653
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/371653 | PI-kinase inhibitors with anti-infective activity | Jul 8, 2021 | Issued |
Array
(
[id] => 17664178
[patent_doc_number] => 11357854
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-14
[patent_title] => Pharmaceutical compositions comprising meloxicam
[patent_app_type] => utility
[patent_app_number] => 17/360574
[patent_app_country] => US
[patent_app_date] => 2021-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 33
[patent_no_of_words] => 23891
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17360574
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/360574 | Pharmaceutical compositions comprising meloxicam | Jun 27, 2021 | Issued |
Array
(
[id] => 17865351
[patent_doc_number] => 20220288086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-15
[patent_title] => TREATMENT FOR BACTERIAL INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/358392
[patent_app_country] => US
[patent_app_date] => 2021-06-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17358392
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/358392 | TREATMENT FOR BACTERIAL INFECTION | Jun 24, 2021 | Abandoned |
Array
(
[id] => 18509944
[patent_doc_number] => 20230226036
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => ARIMOCLOMOL FOR TREATING GAUCHER DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/011349
[patent_app_country] => US
[patent_app_date] => 2021-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10213
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18011349
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/011349 | ARIMOCLOMOL FOR TREATING GAUCHER DISEASE | Jun 23, 2021 | Pending |
Array
(
[id] => 17595299
[patent_doc_number] => 20220144872
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-12
[patent_title] => Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Methods of Making Same
[patent_app_type] => utility
[patent_app_number] => 17/350267
[patent_app_country] => US
[patent_app_date] => 2021-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10945
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17350267
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/350267 | Pharmaceutical-Grade Ferric Organic Compounds, Uses Thereof and Methods of Making Same | Jun 16, 2021 | Abandoned |
Array
(
[id] => 17342100
[patent_doc_number] => 20220008431
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => ADMINISTRATION AND DOSAGE OF DIAMINOPHENOTHIAZINES
[patent_app_type] => utility
[patent_app_number] => 17/349427
[patent_app_country] => US
[patent_app_date] => 2021-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28041
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17349427
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/349427 | Administration and dosage of diaminophenothiazines | Jun 15, 2021 | Issued |
Array
(
[id] => 17556013
[patent_doc_number] => 11312689
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-26
[patent_title] => Compounds and their use for the treatment of alpha1-antitrypsin deficiency
[patent_app_type] => utility
[patent_app_number] => 17/345928
[patent_app_country] => US
[patent_app_date] => 2021-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7063
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17345928
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/345928 | Compounds and their use for the treatment of alpha1-antitrypsin deficiency | Jun 10, 2021 | Issued |
Array
(
[id] => 19012992
[patent_doc_number] => 11919907
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-05
[patent_title] => Deuterated JAK inhibitor and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/327044
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8700
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327044
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/327044 | Deuterated JAK inhibitor and uses thereof | May 20, 2021 | Issued |
Array
(
[id] => 17342110
[patent_doc_number] => 20220008441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-13
[patent_title] => COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS
[patent_app_type] => utility
[patent_app_number] => 17/327395
[patent_app_country] => US
[patent_app_date] => 2021-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13093
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17327395
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/327395 | COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS | May 20, 2021 | Abandoned |
Array
(
[id] => 17170311
[patent_doc_number] => 20210323981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-21
[patent_title] => FREE AMINO COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION
[patent_app_type] => utility
[patent_app_number] => 17/326241
[patent_app_country] => US
[patent_app_date] => 2021-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14518
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17326241
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/326241 | FREE AMINO COMPOUNDS FOR THE TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION | May 19, 2021 | Abandoned |
Array
(
[id] => 18483524
[patent_doc_number] => 20230210822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => PHARMACEUTICAL COMPOSITION FOR TREATING FATTY LIVER DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/926273
[patent_app_country] => US
[patent_app_date] => 2021-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17480
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17926273
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/926273 | PHARMACEUTICAL COMPOSITION FOR TREATING FATTY LIVER DISEASE | May 19, 2021 | Pending |
Array
(
[id] => 18483524
[patent_doc_number] => 20230210822
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => PHARMACEUTICAL COMPOSITION FOR TREATING FATTY LIVER DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/926273
[patent_app_country] => US
[patent_app_date] => 2021-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17480
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17926273
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/926273 | PHARMACEUTICAL COMPOSITION FOR TREATING FATTY LIVER DISEASE | May 19, 2021 | Pending |
Array
(
[id] => 19042263
[patent_doc_number] => 11931336
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-19
[patent_title] => Enhancing autophagy or increasing longevity by administration of urolithins
[patent_app_type] => utility
[patent_app_number] => 17/324490
[patent_app_country] => US
[patent_app_date] => 2021-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 39
[patent_no_of_words] => 79571
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17324490
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/324490 | Enhancing autophagy or increasing longevity by administration of urolithins | May 18, 2021 | Issued |